Journal of Antimicrobial Chemotherapy, Volume 69, Issue 12, Pages 3349–3355, 2014

PMID: 25085657

Increased trends of primary drug resistance mutations (DRMs) among treatment-naive HIV-1-infected patients in low- and middle-income countries (LMICs) and the non-availability of pre-antiretroviral therapy (ART) genotypic resistance testing (GRT) may severely affect future therapeutic outcomes. The main objective of this study was therefore to develop a simplified, cost- and labor-efficient but high-throughput GRT protocol to be applied in the large-scale surveillance of DRMs in LMICs.

Read More

  https://academic.oup.com/jac/article/69/12/3349/818342